Building The YC of Biotech with Zach Weinberg

Zach Weinberg, co-founder and CEO of Curie.Bio, is redefining early-stage biotech investing with an operator’s mindset and a founder-first philosophy. His approach combines funding with operational support and direct access to world-class drug hunters to dramatically increase odds of success. Today, Zach sits down with Nick Chirls, GP at Asylum Ventures and Beezer Clarkson, LP at Sapphire Partners to discuss the massive risk associated with traditional therapeutics startups, how pairing a drug discovery partner with a seed investor solves those inefficiencies, and how biotech, the global economy and the political landscape are all closely connected. Learn more about Sapphire Partners: ⁠ Learn more about OpenLP: ⁠ Learn more about Asylum Ventures: ⁠ Learn more about Curie.Bio: For a monthly roundup of the latest venture insights, including the newest Origins episodes,

You can listen to Building The YC of Biotech with Zach Weinberg online on Radio and Podcast. Open the player on this page to stream the available audio.

Building The YC of Biotech with Zach Weinberg is an episode from Origins - A podcast about Limited Partners, created by Notation Capital by OpenLP from Sapphire Partners.

This episode is 00:58:13 long.

This episode was published on Jun 3, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Origins - A podcast about Limited Partners, created by Notation Capital when more episodes are available from the podcast feed.